Kundu, Amartya
Sardar, Partha
O’Day, Kevin
Chatterjee, Saurav
Owan, Theophilus
Dawn Abbott, J.
Article History
First Online: 23 March 2018
Compliance with Ethical Standards
:
: Amartya Kundu, Partha Sardar, Kevin O’Day, Saurav Chatterjee, and Theophilus Owan declare that they have no conflict of interest.Dr. J. Dawn Abbott reports clinical trial consulting for Pfizer (antihyperlipidemic therapy) and Recor (renal denervation).
: This article does not contain any studies with human or animal subjects performed by any of the authors.